A detailed history of Carlson Capital Management transactions in Abbott Laboratories stock. As of the latest transaction made, Carlson Capital Management holds 7,611 shares of ABT stock, worth $791,696. This represents 0.07% of its overall portfolio holdings.

Number of Shares
7,611
Previous 18,314 58.44%
Holding current value
$791,696
Previous $2.02 Million 57.07%
% of portfolio
0.07%
Previous 0.1%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

SELL
$109.52 - $120.96 $1.17 Million - $1.29 Million
-10,703 Reduced 58.44%
7,611 $865,000
Q4 2023

Jan 16, 2024

BUY
$90.19 - $110.4 $455,730 - $557,851
5,053 Added 38.1%
18,314 $2.02 Million
Q3 2023

Nov 21, 2023

BUY
$95.53 - $114.62 $35,823 - $42,982
375 Added 2.91%
13,261 $1.28 Million
Q2 2023

Jul 24, 2023

BUY
$100.78 - $112.29 $9,876 - $11,004
98 Added 0.77%
12,886 $1.4 Million
Q1 2023

Apr 17, 2023

BUY
$96.86 - $114.01 $12,204 - $14,365
126 Added 1.0%
12,788 $1.29 Million
Q4 2022

Feb 03, 2023

SELL
$95.06 - $111.52 $60,172 - $70,592
-633 Reduced 4.76%
12,662 $1.39 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $11,417 - $13,219
-118 Reduced 0.88%
13,295 $1.29 Million
Q2 2022

Jul 18, 2022

SELL
$102.07 - $123.37 $930,061 - $1.12 Million
-9,112 Reduced 40.45%
13,413 $1.46 Million
Q1 2022

May 24, 2022

SELL
$114.02 - $139.04 $5,130 - $6,256
-45 Reduced 0.2%
22,525 $2.67 Million
Q4 2021

Jan 14, 2022

BUY
$115.53 - $141.46 $4,505 - $5,516
39 Added 0.17%
22,570 $3.18 Million
Q3 2021

Oct 12, 2021

BUY
$116.66 - $129.06 $6,766 - $7,485
58 Added 0.26%
22,531 $2.66 Million
Q2 2021

Jul 12, 2021

SELL
$105.79 - $124.53 $11,213 - $13,200
-106 Reduced 0.47%
22,473 $2.61 Million
Q1 2021

Apr 12, 2021

BUY
$108.84 - $128.23 $17,958 - $21,157
165 Added 0.74%
22,579 $2.71 Million
Q4 2020

Jan 11, 2021

SELL
$105.0 - $114.42 $257,355 - $280,443
-2,451 Reduced 9.86%
22,414 $2.5 Million
Q2 2020

Jul 13, 2020

BUY
$76.57 - $98.0 $131,240 - $167,972
1,714 Added 7.4%
24,865 $2.31 Million
Q1 2020

Apr 27, 2020

SELL
$62.82 - $91.86 $21,295 - $31,140
-339 Reduced 1.44%
23,151 $2.18 Million
Q4 2019

Jan 27, 2020

BUY
$78.51 - $87.4 $43,416 - $48,332
553 Added 2.41%
23,490 $2.04 Million
Q3 2019

Oct 29, 2019

SELL
$81.84 - $88.74 $31,017 - $33,632
-379 Reduced 1.63%
22,937 $1.92 Million
Q2 2019

Jul 15, 2019

SELL
$72.88 - $85.0 $7,288 - $8,500
-100 Reduced 0.43%
23,316 $1.96 Million
Q1 2019

Apr 25, 2019

SELL
$66.22 - $80.06 $1.73 Million - $2.09 Million
-26,122 Reduced 52.73%
23,416 $1.87 Million
Q4 2018

Jan 22, 2019

BUY
$65.56 - $74.27 $29,698 - $33,644
453 Added 0.92%
49,538 $3.58 Million
Q3 2018

Oct 19, 2018

SELL
$60.81 - $73.36 $638,505 - $770,280
-10,500 Reduced 17.62%
49,085 $3.6 Million
Q2 2018

Jul 26, 2018

BUY
$57.57 - $63.54 $28,785 - $31,770
500 Added 0.85%
59,585 $3.63 Million
Q1 2018

Apr 20, 2018

SELL
$56.27 - $63.62 $114,734 - $129,721
-2,039 Reduced 3.34%
59,085 $3.54 Million
Q4 2017

Jan 08, 2018

BUY
$53.68 - $57.47 $2.96 Million - $3.17 Million
55,173 Added 927.12%
61,124 $3.49 Million
Q3 2017

Oct 16, 2017

BUY
$48.06 - $53.64 $286,005 - $319,211
5,951
5,951 $318,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Carlson Capital Management Portfolio

Follow Carlson Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carlson Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Carlson Capital Management with notifications on news.